Can Sanofi Pasteur's New "Intradermal" Fluzone Boost Sales In A Crowded Market?
This article was originally published in The Pink Sheet Daily
The company says the new microinjection system with needles one-and-a-half millimeters long can boost immunization rates.
You may also be interested in...
The five providers of the six approved seasonal influenza vaccines appear to be preparing for a similar season with similar sales in 2011-12 as they had last year.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.